Suppr超能文献

患者报告的结直肠癌筛查障碍的相对重要性。

The relative importance of patient-reported barriers to colorectal cancer screening.

机构信息

Department of Epidemiology and Community Health, School of Medicine, Virginia Commonwealth University, Richmond, Virginia 23298-0212, USA.

出版信息

Am J Prev Med. 2010 May;38(5):499-507. doi: 10.1016/j.amepre.2010.01.020. Epub 2010 Mar 28.

Abstract

BACKGROUND

Colorectal cancer (CRC) screening rates are suboptimal. The most important barriers identified by patients are poorly understood. A comprehensive assessment of barriers to all recommended modalities is needed.

METHODS

In 2007, a questionnaire was mailed to 6100 patients, aged 50-75 years, from 12 family medicine practices in the Virginia Ambulatory Care Outcomes Research Network. People aged 65-75 years and African Americans were oversampled. Patients were asked to rate 19-21 barriers to each of four recommended tests. In 2008, responses were coded on a 5-point scale; higher scores reflected stronger barrier endorsement.

RESULTS

The response rate was 55% (n=3357). Approximately 40% of respondents were aged >/=65 years, 30% were African-American, and 73% were adherent to screening. A clinician's failure to suggest screening and not knowing testing was necessary received the highest mean scores as barriers. Financial concerns and misconceptions were also cited. Barrier scores differed depending on whether respondents were never screened, overdue for screening, or adherent to guidelines. The top five barriers for each modality included test-specific barriers (e.g., handling stool, bowel preparation), which often outranked generic barriers to screening. Not knowing testing was necessary was a top barrier for all tests but colonoscopy.

CONCLUSIONS

Although physician advice and awareness of the need for screening are important, barriers to screening are not homogenous across tests, and test-specific barriers warrant consideration in designing strategies to improve screening rates. Barrier scores differ by screening status, highlighting the need to address prior screening experience. Evidence that patients are more familiar with colonoscopy than with other modalities suggests an opportunity to improve screening rates by educating patients about alternative tests.

摘要

背景

结直肠癌(CRC)筛查率不理想。患者所识别的最重要的障碍仍不清楚。需要对所有推荐方法的障碍进行全面评估。

方法

2007 年,弗吉尼亚州门诊护理结果研究网络的 12 个家庭医疗实践中的 6100 名年龄在 50-75 岁的患者邮寄了一份问卷。对年龄在 65-75 岁和非裔美国人进行了抽样调查。患者被要求对四种推荐的检测方法中的每一种方法的 19-21 种障碍进行评分。2008 年,对回复进行了 5 分制编码;较高的分数反映了更强的障碍认可。

结果

回复率为 55%(n=3357)。约 40%的受访者年龄≥65 岁,30%是非裔美国人,73%的人坚持筛查。医生未能建议筛查以及不知道检查是必要的,这两个因素被认为是最大的障碍。经济问题和误解也被提及。障碍评分因受访者是否从未接受过筛查、是否已过筛查时间或是否遵循指南而有所不同。每种方法的前五大障碍都包括测试特定的障碍(例如,处理粪便,肠道准备),这些障碍通常高于筛查的一般障碍。不知道检查是必要的是所有测试的最大障碍,但不包括结肠镜检查。

结论

尽管医生的建议和对筛查必要性的认识很重要,但筛查障碍在不同的测试中并不相同,因此在设计提高筛查率的策略时,需要考虑测试特定的障碍。筛查状态不同,障碍评分也不同,这突出了需要解决先前的筛查经验。患者对结肠镜检查比其他方法更熟悉的证据表明,通过教育患者了解替代测试,有机会提高筛查率。

相似文献

1
The relative importance of patient-reported barriers to colorectal cancer screening.
Am J Prev Med. 2010 May;38(5):499-507. doi: 10.1016/j.amepre.2010.01.020. Epub 2010 Mar 28.
2
Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis.
Am J Prev Med. 2010 May;38(5):508-16. doi: 10.1016/j.amepre.2010.01.021.
3
Barriers and Facilitators to Colorectal Cancer Screening Among Health Fair Attendees in Utah.
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251316659. doi: 10.1177/21501319251316659.
5
Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.
Med Care. 2008 Sep;46(9 Suppl 1):S10-6. doi: 10.1097/MLR.0b013e31817d932e.
7
Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719884295. doi: 10.1177/2150132719884295.
10
Factors Affecting Colorectal Cancer Screening in Primary Care Physician Practices in Ukraine.
JCO Glob Oncol. 2024 Aug;10:e2400053. doi: 10.1200/GO.24.00053.

引用本文的文献

1
Evaluating the Reliability of OpenAI's ChatGPT-4 in Providing Pre-colonoscopy Patient Guidance.
Cureus. 2025 Jun 21;17(6):e86512. doi: 10.7759/cureus.86512. eCollection 2025 Jun.
4
A socioecological taxonomy of determinants to colorectal cancer screening in black men: Insights from a mixed-methods systematic review.
Prev Med Rep. 2024 Dec 25;49:102954. doi: 10.1016/j.pmedr.2024.102954. eCollection 2025 Jan.
6
Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study.
J Natl Cancer Inst. 2025 Apr 1;117(4):790-794. doi: 10.1093/jnci/djae244.
7
Optimising Surveillance in Hepatocellular Carcinoma: Patient-Defined Obstacles and Solutions.
J Hepatocell Carcinoma. 2024 Aug 23;11:1597-1605. doi: 10.2147/JHC.S462303. eCollection 2024.
8
Colorectal Cancer Polygenic Risk Score Is Associated With Screening Colonoscopy Findings but Not Follow-Up Outcomes.
Gastro Hep Adv. 2023 Oct 10;3(2):151-161. doi: 10.1016/j.gastha.2023.10.001. eCollection 2024.
9
Patient-Provider Communication and Colorectal Cancer Screening Completion Using Multi-target Stool DNA Testing.
J Cancer Educ. 2025 Feb;40(1):115-123. doi: 10.1007/s13187-024-02479-w. Epub 2024 Jul 20.
10

本文引用的文献

1
Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis.
Am J Prev Med. 2010 May;38(5):508-16. doi: 10.1016/j.amepre.2010.01.021.
2
The priority is screening, not colonoscopy.
Am J Public Health. 2009 Dec;99(12):2117-8; author reply 2118. doi: 10.2105/AJPH.2009.177584. Epub 2009 Oct 15.
4
Determinants of colorectal cancer screening in primary care.
J Cancer Educ. 2008;23(4):241-7. doi: 10.1080/08858190802189089.
5
Summaries for patients. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation.
Ann Intern Med. 2008 Nov 4;149(9):I-44. doi: 10.7326/0003-4819-149-9-200811040-00246. Epub 2008 Oct 6.
6
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.
Ann Intern Med. 2008 Nov 4;149(9):659-69. doi: 10.7326/0003-4819-149-9-200811040-00244. Epub 2008 Oct 6.
7
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2008 Nov 4;149(9):627-37. doi: 10.7326/0003-4819-149-9-200811040-00243. Epub 2008 Oct 6.
8
Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening.
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2231-7. doi: 10.1158/1055-9965.EPI-08-0176.
9
Colorectal cancer test use from the 2005 National Health Interview Survey.
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30. doi: 10.1158/1055-9965.EPI-07-2838.
10
Effect of incentives and mailing features on online health program enrollment.
Am J Prev Med. 2008 May;34(5):382-8. doi: 10.1016/j.amepre.2008.01.028.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验